David C. Sneider


David Sneider is a seasoned financial executive who, during his career, contributed significantly to the financial success of many early start-ups, taking them to successful exits including IPO.

Most recently Mr. Sneider served as Vice President and Chief Financial Officer of Nerites Corporation, a venture capital financed company which developed medical devices to aid tissue repair, speed surgical times and reduce postoperative complications. During Mr. Sneider’s tenure, Nerites raised in excess of $12,000,000. Nerites was acquired in 2011 by Kensey Nash Corporation.

From 2006 until 2008, Mr. Sneider served as Vice President and Chief Business Officer of Cellular Dynamics International, Inc. Cellular Dynamics products provide industrialized quantities of genetically diverse, terminally differentiated human cells enabling basic research, efficient drug discovery programs and reliably predictive toxicity and efficacy screening through in vitro clinical trials. Previously, Mr. Sneider had been Vice President and Chief Financial Officer of NimbleGen Systems Inc from 2000 to 2006. NimbleGen was acquired by Roche Diagnostics for $272 million. Before that Mr. Sneider was the Chief Financial Officer and Secretary of Third Wave Technologies, Inc. (TWTI: NASDAQ), from 1997 to 2000. Earlier in his career, Mr. Sneider was Chief Financial Officer, Secretary and Treasurer of Tellabs, Inc. (TLAB: NASDAQ) where he oversaw two public stock offerings including its initial public offering.

Currently, Mr. Sneider serves as advisor to Flex Biomedical, Inc. which is developing novel treatments and diagnostics for orthopedic diseases and as a board member of Sonoplot, Inc. which provides fluid dispensers and chemical surface treatments for microelectronics and the life sciences. Both companies are financed by angel investors.

Mr. Sneider brings considerable business and financial expertise to support Aurora Spectral Technologies’ startup efforts in developing and introducing the OptiMiS TruLine micro-spectroscopy system to scientists throughout the world.